PCM
CABA icon

Prelude Capital Management’s Cabaletta Bio CABA Stock Holding History

Prelude Capital Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$117K Buy
+43,416
New +$121K 0.01% 1026
2025
Q1 		– Sell
-11,001
Closed -$25K – 1219
2024
Q4 		$25K Buy
+11,001
New +$38.6K ﹤0.01% 1171
2024
Q3 		– Sell
-95,200
Closed -$712K – 1297
2024
Q2 		$712K Buy
+95,200
New +$1.17M 0.05% 396
2024
Q1 		– Sell
-11,100
Closed -$252K – 1328
2023
Q4 		$252K Buy
+11,100
New +$187K 0.02% 831

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return